SERAX Drug Patent Profile
✉ Email this page to a colleague
When do Serax patents expire, and when can generic versions of Serax launch?
Serax is a drug marketed by Alpharma Us Pharms and is included in one NDA.
The generic ingredient in SERAX is oxazepam. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the oxazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Serax
A generic version of SERAX was approved as oxazepam by UNITED RES LABS on August 10th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SERAX?
- What are the global sales for SERAX?
- What is Average Wholesale Price for SERAX?
Summary for SERAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 43 |
Patent Applications: | 5,243 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SERAX at DailyMed |
![SERAX drug patent expirations Drug patent expirations by year for SERAX](/p/graph/s/t/SERAX-patent-expirations.png)
US Patents and Regulatory Information for SERAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Alpharma Us Pharms | SERAX | oxazepam | TABLET;ORAL | 015539-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SERAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-006 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-004 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SERAX
See the table below for patents covering SERAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 569902 | ⤷ Sign Up | |
South Korea | 850000974 | ⤷ Sign Up | |
United Kingdom | 2142824 | PHARMACEUTICAL COMPOSITION CONTAINING A LIQUID LUBRICANT | ⤷ Sign Up |
France | 2548539 | COMPOSITION PHARMACEUTIQUE CONTENANT UN LUBRIFIANT LIQUIDE ET PROCEDE POUR AMELIORER LA DISSOLUTION DE CAPSULES EN GELATINE DURE OU DE COMPRIMES CONTENANT DES FORMULES THERAPEUTIQUES ET UN LUBRIFIANT | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |